drugset / Trial / NCT00038558

Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy

NCT00038558

Phase 3 Completed 25 enrolled M.D. Anderson Cancer Center
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Prophylactic use of Filgrastim SD/01 for patients with Hodgkin's lymphoma receiving ABVD chemotherapy.

Timeline

Start
2001-11
Primary completion
2004-02
Completion
2005-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Filgrastim SD/01 Unknown
Background Bleomycin Unknown
Background Dacarbazine Small molecule
Background Doxorubicin Other / unclassified
Background Vinblastine Small molecule

Indications